ライフサイエンスコーパス: increased weight

1 ggesting that there is no healthy pattern of increased weight.

2 ine also increased hypoglycemia and modestly increased weight.

3 e with increased expenditure associated with increased weight.

4 d from malalignment and the excess load from increased weight.

5 the vehicle or MS1 conditions significantly increased weight (9-20 g) and produced smaller reduction

6 1-null mice grow longer than wild type, with increased weight and adiposity, when restricted in vitam

7 Endometrial cancer is associated with increased weight and body size, diabetes, and other cond

8 el of inflammation, Nbs1(B/B) animals showed increased weight and ear thickness.

9 may increase dieting, a risk factor for both increased weight and eating disorders in adolescents.

10 and pediatric isolates were associated with increased weight and gestational age of newborns (P </=

11 osure to reduced rations was associated with increased weight and greater indexes of fat deposition a

12 Iron treatment significantly increased weight and hemoglobin nadirs and provided enha

13 tica pathogenesis, mice lacking Gal-1 showed increased weight and survival, lower bacterial load, and

14 hort-term adverse events-acne, night sweats, increased weight, and altered mood and libido-are recogn

15 e, which results in flies with larger cells, increased weight, and decreased life span compared to wi

16 g the atypical subtype, such as hyperphagia, increased weight, and leaden paralysis.

17 cerebellar Purkinje neurons reduced ataxia, increased weight, and prolonged life, but it did not pre

18 ies also support the notion that fatigue and increased weight are linked to higher osteoarthritis pai

19 Hand OA was significantly associated with increased weight at ages 26 years, 43 years, and 53 year

20 Accordingly, SI compared to DS increased weight by 89 g (95% CI 27, 150; p = 0.005) whe

21 he single mutants had higher oil content and increased weight compared to those of the wild type, wit

22 , and/or lifestyle behaviors account for the increased weight, fat mass, and central adiposity experi

23 Both iron and DHA/EPA significantly increased weight-for-age z scores.

24 pothalamic satiation signaling, hyperphagia, increased weight gain and adiposity, and enhanced lipoge

25 leptin signaling (Leprdb/db mice), including increased weight gain and adiposity, hyperphagia, cold i

26 hat these Npc1(+/-) mice were susceptible to increased weight gain characterized by increased whole b

27 hers and F1 daughters of HFD-fed fathers had increased weight gain compared to controls.

28 glucose intolerance, insulin resistance, and increased weight gain during, but not prior to, pregnanc

29 HFD resulted in 9.7% and 14.7% increased weight gain in male and female F0 respectively

30 fat in black adults and was associated with increased weight gain in Nigerian women.

31 ght gain (diet-induced obese [DIO] rats) had increased weight gain in response to consuming saccharin

32 that daily insulin injections significantly increased weight gain in the transgenic lines expressing

33 ut inducing adverse side effects such as the increased weight gain induced by TZDs.

34 The increased weight gain of SMRT(mRID1) mice on a high-fat

35 ng, whereas group-housed female mice display increased weight gain on high-fat diet, reduced behavior

36 GH administration increased weight gain only in hypoxic animals (p < .001)

37 ted protein 2 antibodies was associated with increased weight gain with either intensive or conventio

38 These data support the hypothesis that increased weight gain with intensive therapy might be ex

39 hort day hamsters were also characterized by increased weight gain, and heavier adrenal glands (p < 0

40 nd cardiovascular disease-related mortality, increased weight gain, and high risk for severe hypoglyc

41 IL-18R(-/-) mice display increased weight gain, ectopic lipid deposition, inflamm

42 rdination and cognitive function but exhibit increased weight gain, elevated white adipose tissue dep

43 Unexpectedly, CD40(-/-) mice exhibited increased weight gain, impaired insulin secretion, augme

44 Although not exhibiting increased weight gain, male CD40(-/-) mice in DIO displa

45 g insulin concentrations are associated with increased weight gain, whereas insulin resistance seems

46 ed glucose tolerance only secondary to their increased weight gain.

47 essive gestational weight gain may result in increased weight in children; however, studies have not

48 ld have an important role in the response to increased weight in people.

49 43% of the patients), diarrhea (in 39%), and increased weight (in 26%).

50 order of magnitude variation in body weight; increased weight is supported solely through disproporti

51 Pioglitazone increased weight less among patients at higher risk but

52 ggest that, despite a known association with increased weight, long-term sulfonylurea therapy may red

53 ctive protein concentrations correlated with increased weight loss (r = 0.24, P < 0.001).

54 MC4R (I251L), a rare variant associated with increased weight loss after RYGB and increased basal act

55 ulted in more severe disease, as measured by increased weight loss and airway resistance, as compared

56 istering DSS to IL-17R(-/-) mice resulted in increased weight loss and more severe intestinal inflamm

57 en in mice infected with M. tuberculosis and increased weight loss and mortality in mice infected wit

58 ore susceptible to endotoxemia, evidenced by increased weight loss and serum TNF-alpha, IL-6, and IL-

59 and intestinal-secreted IgA correlated with increased weight loss at the end of DSS administration.

60 a significantly reduced survival percentage, increased weight loss, and a more-rapid increase in bact

61 ctivated RSV-vaccinated children, as well as increased weight loss, clinical illness, and enhanced pa

62 zed with vacvG results in the development of increased weight loss, clinical illness, and Penh simila

63 s in exacerbated disease severity, including increased weight loss, morbidity, and enhanced airway re

64 BS >/=40 was associated with increased weight loss.

65 Reduced amount of ovarian fluid and increased weight of the ovarian sac indicate disturbance

66 The placentas showed a trend to increased weight (OT1DM 690 + or - 19 g; control 641 + o

67 ermediate variables and may not be caused by increased weight per se.

68 stature, black race, age 55 years or older, increased weight, rapid pulse, and smoking history (< or

69 Carbohydrate overfeeding increased weight (+/-SEM) by 2% (1.8 +/- 0.3 kg; P < 0.0

70 -fast blood glucose normally associated with increased weight, suggesting a role for resistin in medi

71 Rats gradually increased weight support.

72 ethoxy-4-iodophenyl-2-aminopropane), further increased weight-supported stepping in transplant rats.

73 rease of energy intake needed to sustain the increased weight (the maintenance energy gap) has amount

74 ice with equal mean body weights (42 and 58% increased weight versus lean mice).

75 ce estimates using Gray's k-sample P values, increased weight was ascribed to the earlier data becaus